CEO Spotlight: Michael Forbes – Leading the Way in Future Health and Longevity 

Covid-19 Isn’t Over: Hospitalizations Ups, Vaccines Down and Cannabis Reducing Symptoms? 

The Hidden Epidemic in Your Pantry: Time for a Food Safety Revolution

Are you ready for AI in healthcare?

Unleashing the Potential of Psychedelic Lifestyle Products: Exploring Investment Opportunities

Biohacking: Unlocking the Future of Optimal Health

Emerging Biotech Breakthroughs: Promising Stocks in Medical Innovation

Unveiling the Upcoming Trends in Big Pharma Stocks for 2023: Key Players and Emerging Opportunities

Recent News

Masimo, amid leadership transition, targets cost reductions

In its first earnings report since the departure of longtime CEO Joe Kiani, Masimo said Tuesday it is focused on

Tempus AI to buy genetic testing company for $600M

Tempus AI agreed to buy genetic testing company Ambry Genetics for $375 million in cash and $225 million in shares.

Advamed asks CMS to cover extra imaging of dense breast tissue

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief:

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

Subscribe

* indicates required

Latest Pharma News

One biotech is looking to lessen antipsychotic-induced weight gain, despite new entrants

Re­sponse Phar­ma­ceu­ti­cals be­lieves its ex­per­i­men­tal drug can lessen the per­sis­tent weight gain as­so­ci­at­ed with an­tipsy­chotics. In a new pi­lot study,

Cerebral to pay nearly $3.7M over controlled substance prescribing practices

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your

Latest Cannabis News

Scotts Miracle-Gro Cannabis Unit Q4 Revenue Falls 46%

ScottsMiracle-Gro Reports Fiscal 2024 Fourth Quarter and Full-Year Results U.S. Consumer fiscal 2024 sales up 6 percent in line with

Agrify Adds $10 Million and an Interim CEO from Green Thumb Industries

Agrify Secures Financing from Green Thumb Industries and Announces New Leadership TROY, Mich., Nov. 05, 2024 (GLOBE NEWSWIRE) — Agrify

Latest biotech News

Masimo, amid leadership transition, targets cost reductions

In its first earnings report since the departure of longtime CEO Joe Kiani, Masimo said Tuesday it is focused on

Tempus AI to buy genetic testing company for $600M

Tempus AI agreed to buy genetic testing company Ambry Genetics for $375 million in cash and $225 million in shares.

Latest Life Science News

Multitarget stool DNA test shows promise for early colorectal cancer detection

A recent prospective cross-sectional study in Thailand demonstrates that multitarget stool DNA testing is highly sensitive and specific for detecting

Nanoscale sensor detects lung cancer through breath chemistry

Exhaled breath contains chemical clues to what’s going on inside the body, including diseases like lung cancer.

Latest psychedelics News

Question 4 Fails: Massachusetts Says No to State-Regulated Psychedelics Access and Decriminalisation – Psychedelic Alpha

Massachusetts looks set to reject Question 4, the only standalone psychedelic policy reform initiative to go before the electorate during

Psychedelics on the Ballot 2024 – Psychedelic Alpha

What is Question 4? The only standalone psychedelic policy reform initiative to go before voters at this election is Massachusetts’

videos